Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

A new and rapid method of labeling peptides with F-18

Peter Laverman, Bill McBride, David Goldenberg, Ingrid Dijkgraaf, Annemarie Eek, Lieke Joosten, Robert Sharkey, Wim Oyen and Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 198;
Peter Laverman
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bill McBride
3Immunomedics, Inc., Morris Plains, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Goldenberg
2Center of Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Dijkgraaf
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemarie Eek
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lieke Joosten
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Sharkey
2Center of Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Oyen
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Boerman
1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 198

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Peter Laverman1,
  2. Bill McBride3,
  3. David Goldenberg2,
  4. Ingrid Dijkgraaf1,
  5. Annemarie Eek1,
  6. Lieke Joosten1,
  7. Robert Sharkey2,
  8. Wim Oyen1 and
  9. Otto Boerman1
  1. 1Dept of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
  2. 2Center of Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ
  3. 3Immunomedics, Inc., Morris Plains, NJ

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to May 2025

AbstractFullPdf
Dec 2014200
Apr 2015300
May 2015100
Jun 2015200
Jul 2015100
Aug 2015200
Sep 2015600
Nov 2015200
Mar 2016100
Sep 2016200
Oct 2016200
Nov 2016200
Dec 2016100
Jan 2017100
Feb 2017200
Mar 2017300
Apr 2017600
Jul 2017200
Aug 2017100
Sep 2017200
Oct 2017200
Nov 2017100
Jan 2018100
Apr 2018100
May 20181100
Jun 20182600
Sep 2018200
Nov 2018100
Dec 2018100
Mar 2019200
Apr 2019100
May 2019300
Jul 2019100
Sep 2019100
Nov 2019100
Jan 2020300
Feb 2020400
Mar 20202300
Apr 2020800
May 2020100
Jun 2020200
Jul 2020300
Aug 20202600
Sep 20204500
Oct 2020700
Nov 20201600
Dec 2020700
Jan 2021500
Feb 20211600
Mar 20211000
Apr 20211000
May 20211000
Jun 2021400
Jul 20211100
Aug 20212800
Sep 2021700
Oct 20212400
Nov 20215700
Dec 20213000
Jan 20224200
Feb 20221200
Mar 2022600
Apr 2022500
May 20221300
Jun 2022200
Aug 2022300
Sep 2022100
Oct 2022200
Dec 2022300
Jan 2023400
Feb 2023100
Mar 2023400
Apr 2023500
May 2023300
Jun 2023200
Jul 2023100
Aug 2023500
Sep 2023200
Oct 2023500
Nov 2023100
Dec 2023200
Jan 2024700
Mar 2024400
Apr 2024600
May 2024100
Jun 2024300
Jul 2024100
Aug 2024600
Sep 2024400
Oct 2024200
Nov 2024300
Dec 2024200
Jan 2025500
Feb 2025200
Mar 2025400
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new and rapid method of labeling peptides with F-18
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A new and rapid method of labeling peptides with F-18
Peter Laverman, Bill McBride, David Goldenberg, Ingrid Dijkgraaf, Annemarie Eek, Lieke Joosten, Robert Sharkey, Wim Oyen, Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 198;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A new and rapid method of labeling peptides with F-18
Peter Laverman, Bill McBride, David Goldenberg, Ingrid Dijkgraaf, Annemarie Eek, Lieke Joosten, Robert Sharkey, Wim Oyen, Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 198;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

  • Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
  • 18F-Peptide probe for PET imaging of VEGF expression
  • Synthesis of optically pure 4-fluoro-L-glutamines as potential tumor imaging agents
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

New Radiopharmaceuticals-Novel Probe Development I: Peptides

  • microPET Imaging of integrin α2β1 expression using 64Cu-labeled DGEA peptides
  • The measurement of in vitro and in vivo expression of urokinase-type plasminogen activiator receptor (uPAR) in human breast cancer cells, using 111In-anti-uPAR
  • Synthesis and evaluation of F-18-exendin as a potential biomarker to measure pancreatic beta-cell mass
Show more New Radiopharmaceuticals-Novel Probe Development I: Peptides

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire